TSPT

Transcept Pharmaceuticals, Inc. News Headlines

$2.13
*  
0.05
2.29%
Get TSPT Alerts
*Delayed - data as of Sep. 15, 2014  -  Find a broker to begin trading TSPT now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Sector Update: Healthcare Stocks Stretching Out Gains Near Finish Line; Transcept Pharma Jumps Over 20% Following $333 Mln Deal with Privately Held Rival
7/1/2014 3:58:14 PM - MT Newswires

Sector Update: Healthcare
7/1/2014 3:55:59 PM - MT Newswires

Transcept Pharma And Paratek Pharma To Merge
7/1/2014 6:33:00 AM - RTT News

Transcept Pharmaceuticals, Inc. (TSPT) Ex-Dividend Date Scheduled for June 04, 2014
6/3/2014 9:00:01 AM - NASDAQ.com News

Non-Operating Income Hidden In Operating Earnings
6/18/2013 7:47:00 AM - Seeking Alpha

SmithOnStocks Opines On Stocks: May 19th Edition
5/19/2013 8:32:00 PM - Seeking Alpha

SmithOnStocks Opines On Recent Biotech News
5/13/2013 5:38:00 AM - Seeking Alpha

Transcept: Throwing In The Towel On Intermezzo
5/9/2013 10:46:00 AM - Seeking Alpha

Narrower-than-Expected Loss at Seattle Genetics - Analyst Blog
5/8/2013 10:25:10 AM - Zacks.com

AMAG Narrows Loss; Maintains View - Analyst Blog
4/24/2013 4:09:51 PM - Zacks.com

Merck - BMY in HCV Deal - Analyst Blog
4/23/2013 6:09:40 PM - Zacks.com

Merck In-Licenses from Xenon - Analyst Blog
4/22/2013 6:11:06 PM - Zacks.com

PSTI Plans to Start Phase I Study - Analyst Blog
4/19/2013 4:11:14 PM - Zacks.com

Achillion's HCV Candidates Progress - Analyst Blog
4/17/2013 5:12:52 PM - Zacks.com

Actelion Beats Earnings, Sales Rise - Analyst Blog
4/16/2013 7:08:40 PM - Zacks.com

Repros Gets Additional Patents - Analyst Blog
4/12/2013 5:09:02 PM - Zacks.com

Sanofi Unveils Bond Issue Pricing - Analyst Blog
4/9/2013 4:08:12 PM - Zacks.com

Positive Data on Repros' Androxal - Analyst Blog
4/4/2013 5:09:21 PM - Zacks.com

Positive Results on AMAG's Feraheme - Analyst Blog
3/18/2013 6:47:01 PM - Zacks.com

Alexion Pharma Upgraded to Outperform - Analyst Blog
3/15/2013 2:48:02 PM - Zacks.com

Tonix Readies For Pivotal Fibromyalgia Program
3/13/2013 5:35:09 AM - SeekingAlpha

Transcept: The Prescription Trend Watch For Intermezzo Is On
2/14/2013 6:29:00 PM - Seeking Alpha

Transcept: Purdue Fires Big Marketing Guns And FDA Issues Insomnia Drug Guidelines That Help Intermezzo
1/23/2013 5:35:00 AM - Seeking Alpha

Transcept: Direct To Consumer Advertising Campaign Could Be Tipping Point For Intermezzo
12/7/2012 3:16:00 PM - Seeking Alpha

What Is Next For Transcept Pharmaceuticals After Disappointing Intermezzo Launch?
12/6/2012 1:20:00 PM - Seeking Alpha